P0231: Validation and Reformation of the Red Flags Index: Build a Tool of the Early Diagnosis of Crohn's DiseaseECCO'25Year: 2025
Authors: Fu, X.(1)*;Li, J.(1);Lu, Y.(2);Jin, S.(3);Zhu, L.(1);
(1)Union Hospital- Tongji Medical College- Huazhong University of Science and Technology, Department of Gastroenterology, Wuhan, China;(2)First Hospital of Yangtze University, Department of Gastroenterology, Jingzhou, China;(3)Taihe Hospital- Hubei University of Medicine, Department of Gastroenterology, Shiyan, China;
Fiorino G, Bonovas S, Gilardi D, et al. Validation of the Red Flags Index for Early Diagnosis of Crohn’s Disease: A Prospective Observational IG-IBD Study Among General Practitioners. J Crohns Colitis. 2020;14(12):1777-1779. doi:10.1093/ecco-jcc/jjaa111 2. Danese S, Fiorino G, Mary JY, et al. Development of Red Flags Index for Early Referral of Adults with Symptoms and Signs Suggestive of Crohn’s Disease: An IOIBD Initiative. J Crohns Colitis. 2015;9(8):601-606. doi:10.1093/ecco-jcc/jjv067
P0232: Increasing awareness of joint symptoms in Inflammatory Bowel Disease clinic using recognised clinical joint pain scoring symptoms may aid early diagnosis of spondyloarthropathyECCO'25Year: 2025
Authors: Kerr, H.(1)*;Clarke, M.(1);Connaughton, R.(1);Elsiddig, M.(1);Hall, B.(1);Farrell, R.(1);Smyth, C.(1);Kelly, O.(1);
(1)Connolly Hospital Blanchardstown, Gastroenterology, Dublin, Ireland;
P0233: Prevalence and characteristics of short bowel syndrome in Crohn's disease: a retrospective observational single centre study.ECCO'25Year: 2025
Authors: Laffusa, A.(1)*;Viganò, C.(2);Pirola, L.(2);Hu, W.(3);Mulinacci, G.(4);Gallo, C.(2);Savino, A.(2);Fichera, M.(2);Sampietro, G.M.(5);Invernizzi, P.(2);Massironi, S.(6);
(1)Fondazione IRCCS San Gerardo dei Tintori, Division of Gastroenterology- Center for Autoimmune Liver Diseases- Department of Medicine and Surgery- University of Milano- Bicocca. European Reference Network on Hepatological Diseases ERN RARE-LIVER-, Monza, Italy;(2)Fondazione IRCCS San Gerardo dei Tintori, Division of Gastroenterology- Center for Autoimmune Liver Diseases- Department of Medicine and Surgery- University of Milano- Bicocca. European Reference Network on Hepatological Diseases ERN RARE-LIVER, Monza, Italy;(3)University of Milano-Bicocca, Division of Gastroenterology- Center for Autoimmune Liver Diseases- Department of Medicine and Surgery, Monza, Italy;(4)Fondazione IRCCS San Gerardo Dei Tintori, Interventional Endoscopy Unit-, Monza, Italy;(5)Rho Memorial Hospital- ASST Rhodense, Division of General and HPB Surgery- Department of Medicine and Surgery- Università degli Studi di Milano, Milano, Italy;(6)IRCCS Ospedale San Raffaele, Medicine and Surgery Department- Vita-Salute San Raffaele University, Milano, Italy;
P0234: Predicting factors for long-term outcomes of intestinal Behçet's disease in JapanECCO'25Year: 2025
Authors: Murakami, K.(1);Ihara, S.(1)*;Fujishiro, M.(1);
(1)The University of Tokyo, Gastroenterology, Tokyo, Japan;
P0235: Intestinal Ultrasound and Its Advanced Modalities in Characterizing Strictures in Crohn's DiseaseECCO'25Year: 2025
Authors: de Voogd, F.(1)*;Beek, K.(2);Pruijt, M.(1);Van Rijn, K.(2);van der Bilt, J.(3);Buskens, C.(3);Bemelman, W.(3);Neefjes-Borst, E.A.(4);Mookhoek, A.(5);D'Haens, G.(1);Stoker, J.(2);Gecse, K.(1);
(1)University of Amsterdam- Amsterdam University Medical Center, Department of Gastroenterology and Hepatology, Amsterdam, The Netherlands;(2)University of Amsterdam- Amsterdam University Medical Center, Department of Radiology and Nuclear Medicine, Amsterdam, The Netherlands;(3)University of Amsterdam- Amsterdam University Medical Center, Department of Surgery, Amsterdam, The Netherlands;(4)University of Amsterdam- Amsterdam University Medical Center, Department of Pathology, Amsterdam, The Netherlands;(5)University of Bern, Institute of Tissue Medicine and Pathology, Bern, Switzerland;
1. Bettenworth D, Baker ME, Fletcher JG, et al. A global consensus on the definitions, diagnosis and management of fibrostenosing small bowel Crohn’s disease in clinical practice. Nature Reviews Gastroenterology & Hepatology. 2024:1-13.
2. Bettenworth D, Bokemeyer A, Baker M, et al. Assessment of Crohn’s disease-associated small bowel strictures and fibrosis on cross-sectional imaging: a systematic review. Gut. 2019;68(6):1115-1126.
P0236: Diaphragmatic ultrasound investigation to discriminate sarcopenic index in a population of patients with ibdECCO'25Year: 2025
Authors: Palmisano, C.M.(1)*;Dell'Aquila, P.(2);Cormio, S.(3);Borraccino, A.V.(2);Squeo, F.(2);Savino, F.(2);Novielli, D.(2);Forastiere, D.(3);Principi, M.R.D.(2);
(1)Policlinico di Bari, Internal Medicine Unit "C. Frugoni"- Department of Interdisciplinary Medicine, Bari, Italy;(2)University of Bari, Section of Gastroenterology- Department of Precision and Regenerative Medicine and Ionian Area-, Bari, Italy;(3)University of Bari, Section of Gastroenterology- Department of Precision and Regenerative Medicine and Ionian Area, Bari, Italy;
P0237: Opportunity for action in Spanish IBD patients with Sub-optimal Disease Control: Subanalysis of IBD-PODCAST StudyECCO'25Year: 2025
Authors: Gómez, E.(1);Rubio, S.(2);Suárez, P.(3);Vera, M.I.(4);Paredes, J.M.(5);Hernández-Camba, A.(6);Plaza, R.(7);Mañosa, M.(8);Pajares, R.(9);Sicilia, B.(10);Madero, L.(11);Vega, P.(12);Huguet, J.M.(13);Santos de Lamadrid, R.(14);Michelena, N.(14);García, M.(14);Gomollón Garcia, F.(15)*;
(1)Hospital Universitario Juan Ramón Jiménez, Department of Digestive Service and Gastroenterology, Huelva, Spain;(2)Hospital Universitario de Navarra, Department of Digestive Service and Gastroenterology, Pamplona, Spain;(3)Complejo Asistencial Universitario de León, Department of Digestive Service and Gastroenterology, León, Spain;(4)Hospital Universitario Puerta de Hierro, Department of Digestive Service and Gastroenterology, Madrid, Spain;(5)Hospital Universitario Dr. Peset, Department of Digestive Service and Gastroenterology, Valencia, Spain;(6)Hospital Universitario Nuestra Señora de Candelaria, Department of Digestive Service and Gastroenterology, Santa Cruz de Tenerife, Spain;(7)Hospital Universitario Infanta Leonor, Department of Digestive Service and Gastroenterology, Madrid, Spain;(8)Hospital Universitario Germans Trias i Pujol- Barcelona, Department of Digestive Service and Gastroenterology- CIBERehd, Barcelona, Spain;(9)Hospital Universitario Infanta Sofía, Department of Digestive Service and Gastroenterology, Madrid, Spain;(10)Hospital Universitario de Burgos, Department of Digestive Service and Gastroenterology, Burgos, Spain;(11)Hospital General de Alicante, Instituto de Investigación Sanitaria y Biomédica de Alicante ISABIAL. Servicio de Medicina Digestiva, Alicante, Spain;(12)Complejo Hospitalario Universitario de Ourense, Department of Digestive Service and Gastroenterology, Orense, Spain;(13)Hospital General Universitario de Valencia, Department of Digestive Service and Gastroenterology, Valencia, Spain;(14)AbbVie Inc., Medical Affairs and Health Impact, Chicago, United States;(15)University Hospital Clinic Lozano Blesa, Department of Digestive Service and Gastroenterology- CIBERehd, Zaragoza, Spain;
1. Gordon H, Minozzi S, Kopylov U, et al. ECCO Guidelines on Therapeutics in Crohn's Disease: Medical Treatment. J Crohns Colitis 2024: jjae091.
2. Kim KO. Endoscopic activity in inflammatory bowel disease: clinical significance and application in practice. Clin Endosc 2022;55(4):480-488.
3. Pathirana WPNGW, Paul Chubb SA, Gillet MJ, Vasikaran SD. Faecal calprotectin. Clin Biochem Rev 2018;39(3):77-90.
4. Vega P, Huguet JM, Gómez E, et al. IBD-PODCAST Spain: A Close Look at Current Daily Clinical Practice in IBD Management. Dig Dis Sci 2024;69(3):749-765.
P0238: Reliability of magnetic resonance imaging indices for evaluating perianal fistulizing disease activity in paediatric Crohn’s diseaseECCO'25Year: 2025
Authors: Crowley, E.(1,2)*;Karpewycz, J.(3);Watson, T.A.(4);Rimola, J.(5);Schneider, R.(6);Alsabban, Z.(7);Cytter-Kuint, R.(8);Ma, C.(2,9,10);Zou, G.(2,11);Lewindon, P.J.(12);Gee, M.S.(13,14);Hyams, J.S.(15);Rosen, M.J.(16);von Allmen, D.(17,18);de Buck van Overstraeten , A.(19);Shackelton, L.(2);Rémillard, J.(2);Ashton , H.(2);Dillman, J.R.(20,21);Taylor, S.A.(22);Fletcher, J.(23);Church, P.C.(24);Feagan, B.(2,11,25);Griffiths, A.M.(24);Jairath, V.(2,11,25);Greer, M.L.C.(26,27);
(1)Children's Hospital Western Ontario- Western University, Department of Pediatrics- Division of Paediatric Gastroenterology- Hepatology and Nutrition-, London, Canada;(2)Alimentiv Inc., Medical R&D, London, Canada;(3)University of Toronto, The Hospital for Sick Children, Toronto, Canada;(4)Great Ormond Street Hospital for Children- NHS Foundation Trust, Department of Clinical Radiology, London, United Kingdom;(5)Hospital Clinic Barcelona- IDIBAPS, IBD Unit- Radiology Department, Barcelona, Spain;(6)Montreal Children’s Hospital- McGill University, Department of Pediatrics- Division of Gastroenterology and Nutrition, Montreal, Canada;(7)King Faisal Specialist Hospital and Research Centre, Department of Radiology, Jeddah, Saudi Arabia;(8)Shaare Zedek Medical Center- The Hebrew University of Jerusalem, Radiology Department, Jerusalem, Israel;(9)University of Calgary, Department of Medicine- Division of Gastroenterology & Hepatology, Calgary, Canada;(10)University of Calgary, Department of Community Health Sciences-, Calgary, Canada;(11)Western University, Department of Epidemiology and Biostatistics, London, Canada;(12)Queensland Children's Hospital- University of Queensland, Department of Gastroenterology, Brisbane, Australia;(13)Massachusetts General Hospital, Department of Radiology, Boston, United States;(14)Harvard Medical School, Department of Radiology, Boston, United States;(15)Connecticut Children's Medical Center, Division of Digestive Diseases- Hepatology- and Nutrition, Hartford, United States;(16)Stanford Medicine, Department of Pediatrics- Division of Pediatric Gastroenterology- Hepatology and Nutrition, Stanford, United States;(17)Cincinnati Children's Hospital Medical Center, Department of Pediatric Surgery and Surgical Services, Cincinnati, United States;(18)University of Cincinnati College of Medicine, Department of Surgery, Cincinnati, United States;(19)Mount Sinai Hospital- University of Toronto, Department of Surgery, Toronto, Canada;(20)Cincinnati Children's Hospital Medical Center, Department of Radiology, Cincinnati, United States;(21)University of Cincinnati College of Medicine, Department of Radiology, Cincinnati, United States;(22)University College London, Centre for Medical Imaging, London, United Kingdom;(23)Mayo Clinic, Department of Radiology, Rochester, United States;(24)IBD Center- Hospital for Sick Children- University of Toronto, Division of Pediatric Gastroenterology, Toronto, Canada;(25)Western University, Department of Medicine- Division of Gastroenterology, London, Canada;(26)The Hospital for Sick Children, Department of Diagnostic and Interventional Radiology, Toronto, Canada;(27)University of Toronto, Department of Medical Imaging, Toronto, Canada;
1. Crowley E, Ma C, Guizzetti L, Zou G, Lewindon PJ, Gee MS, et al. Recommendations for Standardizing MRI-based Evaluation of Perianal Fistulizing Disease Activity in Pediatric Crohn's Disease Clinical Trials. Inflamm Bowel Dis. 2024;30(3):357-69.
2. Zou GY. Sample size formulas for estimating intraclass correlation coefficients with precision and assurance. Statistics in Medicine. 2012;31(29):3972-398
3. Landis JR, Koch GG. The measurement of observer agreement for categorical data. Biometrics. 1977;33(1):159-74.
P0239: Sexual quality of life and patient-healthcare communication in Inflammatory Bowel Disease: a comprehensive single-center analysisECCO'25Year: 2025
Authors: Saidani, R.(1)*;Cherif, D.(1);Hassine, H.(1);Yacoub, H.(1);Debbabi, H.(1);Kchir, H.(1);Maamouri, N.(1);
(1)University hospital of La Rabta, Gastroenterology B, Tunis, Tunisia;
P0240: Cross-cultural adaptation and validation of the Crohn’s Anal Fistula – Quality of Life scale in Dutch patients with active perianal fistulizing Crohn’s diseaseECCO'25Year: 2025
Authors: Bak, M.T.J.(1);Pierik, R.J.(1)*;Rizopoulos, D.(2);Buskens, C.J.(3);van der Bilt, J.D.W.(4);de Boer, N.K.H.(5);Gecse, K.B.(5);Mundt, M.W.(6);Witjes, C.D.M.(7);Fitzpatrick, C.E.(8);Nissen, L.H.C.(9);Verdaasdonk, E.G.G.(10);Hoogenboom, F.J.(11);Visschedijk, M.C.(12);Stassen, L.P.S.(13);van Ruler, O.(14);de Vries, A.C.(1);
(1)Erasmus Medical Center, Department of Gastroenterology and Hepatology, Rotterdam, The Netherlands;(2)Erasmus Medical Center, Department of Biostatistics, Rotterdam, The Netherlands;(3)Amsterdam UMC, Department of Surgery, Amsterdam, The Netherlands;(4)Flevo Ziekenhuis, Department of Surgery, Almere, The Netherlands;(5)Amsterdam UMC, Department of Gastroenterology and Hepatology, Amsterdam, The Netherlands;(6)Flevo Ziekenhuis, Department of Gastroenterology and Hepatology, Almere, The Netherlands;(7)IJsselland Ziekenhuis, Department of Surgery, Capelle aan den IJssel, The Netherlands;(8)IJsselland Ziekenhuis, Department of Gastroenterology and Hepatology, Capelle aan den IJssel, The Netherlands;(9)Jeroen Bosch Ziekenhuis, Department of Gastroenterology and Hepatology, 's-Hertogenbosch, The Netherlands;(10)Jeroen Bosch Ziekenhuis, Department of Surgery, 's-Hertogenbosch, The Netherlands;(11)University Medical Center Groningen, Department of Surgery, Groningen, The Netherlands;(12)University Medical Center Groningen, Department of Gastroenterology and Hepatology, Groningen, The Netherlands;(13)Maastricht University Medical Center, Department of Surgery, Maastricht, The Netherlands;(14)IJsselland Ziekenhuis, Surgery, Department of Capelle aan den IJssel, The Netherlands; Dutch Initiative on Crohn and Colitis and the Dutch Initiative on Crohn and Colitis – Surgery
References
1. Panes J, Reinisch W, Rupniewska E, et al. Burden and outcomes for complex perianal fistulas in crohn's disease: Systematic review. World J Gastroenterol 2018;24:4821-34
2. Adegbola SO, Dibley L, Sahnan K, et al. Development and initial psychometric validation of a patient-reported outcome measure for Crohn's perianal fistula: the Crohn's Anal Fistula Quality of Life (CAF-QoL) scale. Gut. 2021;70(9):1649-1656.
3. Irvine EJ, Zhou Q, Thompson AK. The Short Inflammatory Bowel Disease Questionnaire: a quality of life instrument for community physicians managing inflammatory bowel disease. CCRPT Investigators. Canadian Crohn's Relapse Prevention Trial. Am J Gastroenterol. 1996;91(8):1571-1578.
4. Herdman M, Gudex C, Lloyd A, et al. Development and preliminary testing of the new five-level version of EQ-5D (EQ-5D-5L). Qual Life Res. 2011;20(10):1727-1736.
P0241: The DETECTION Study: DETection by Endoscopy of Colitis in Screening ImplementaTIONECCO'25Year: 2025
Authors: Lloyd, A.(1)*;Hanly, M.(1);Nolan, B.(1);Doran, R.(1);McCarville, L.(1);Macmathuna, P.(1);Coffey, H.(1);Adetona, O.(1);Rajan, M.(1);Dokic, D.(1);Manj, J.(1);Morahan, F.(1);Lucey, M.(1);Walsh, N.(1);Musial , O.(1);Sugrue, K.(1);Twomey, R.(1);O'Sullivan, C.(1);O'Brien, L.(1);Gleeson, S.(1);Sheehan, D.(1);McDonald, C.(1);Moran, C.(1);Buckley, M.(1);Iacucci, M.(1);McDermott, E.(1);Cullen, G.(1);Horgan, G.(1);Mulcahy, H.(1);Buckley, M.(1);Sheridan, J.(1);Egan, L.(1);Kevans, D.(1);McCarthy, J.(1);Leydan, J.(1);O'Toole, A.(1);Macnamara, D.(1);Slattery, E.(1);Boland, K.(1);Doherty, G.(1);
(1)INITIATIVE Research Group, Gastroenterology Dept, Dublin, Ireland;
P0242: Improving quality in IBD – evaluation of corticosteroid excess prescription trends and its predictive role in disease-related outcomesECCO'25Year: 2025
Authors: Damasceno, J.(1)*;Guimarães, A.(1);Carvalho, T.(1);Neves, J.(1);Arroja, B.(1);Soares, J.(1);Rebelo, A.(1);Mendes, S.(1);Gonçalves, R.(1);Tiago, L.(1);
(1)Braga Hospital, Gastroenterology, Braga, Portugal;
[1]K. Rosiou, J. Carbonell, V. Dolby, N. Monfared, T. Raine, and C. P. Selinger, ‘Sources of excess steroid prescriptions and clinical adverse outcomes associated with steroid excess in patients with inflammatory bowel disease: The Leeds IBD Steroids study’, Aliment Pharmacol Ther, vol. 56, no. 3, pp. 501–509, Aug. 2022, doi: 10.1111/apt.17039.
[2]L. E. Targownik, Z. Nugent, H. Singh, and C. N. Bernstein, ‘Prevalence of and Outcomes Associated with Corticosteroid Prescription in Inflammatory Bowel Disease’:, Inflammatory Bowel Diseases, vol. 20, no. 4, pp. 622–630, Apr. 2014, doi: 10.1097/MIB.0000000000000008.
[3]L. Goran and L. Negreanu, ‘Improvement of quality of care in inflammatory bowel disease: the role of Steroid Assessment Tool (SAT)-results from a tertiary center trial’, Rev. Med. Mod., vol. 28, no. 1, pp. 49–54, Mar. 2021, doi: 10.31689/rmm.2021.28.1.49.
[4]C. P. Selinger et al., ‘Assessment of steroid use as a key performance indicator in inflammatory bowel disease—analysis of data from 2385 UK patients’, Aliment Pharmacol Ther, vol. 50, no. 9, pp. 1009–1018, Nov. 2019, doi: 10.1111/apt.15497.
P0243: Evaluation of liver fibrosis and steatohepatitis associated with metabolic dysfunction (MASH) in patients with inflammatory bowel disease (IBD) and steatotic liver disease associated with metabolic dysfunction (MASLD).ECCO'25Year: 2025
Authors: Oliveira, E.C.S.D.(1)*;Lopes, M.A.(1);Beraldo, R.F.(1);Castelhano, N.S.(1);Baima, J.P.(1);Herrerias , G.S.P.(1);Quaglio, A.E.V.(2);Di Stasi, L.C.(3);Barbosa, W.F.(1);Silva , G.F.(1);Sassaki, L.Y.(1);
(1)São Paulo State University Unesp- Medical School, Department of Internal Medicine, Botucatu, Brazil;(2)Verum Ingredients, Botucatu Technology Park, Botucatu, Brazil;(3)São Paulo State University Unesp- Institute of Biosciences, Department of Biophysics and Pharmacology, Botucatu, Brazil;
P0244: Serum IgLC Levels in Ulcerative Colitis: Limited Utility as Biomarkers for Disease ActivityECCO'25Year: 2025
Authors: Oh, J.E.(1)*;Park, J.J.(1);Choi, S.(1);Park, J.(1);Park, S.J.(1);Kim, T.I.(1);Cheon, J.H.(1);
(1)Severance Hospital- Yonsei University College of Medicine, Department of Internal Medicine, Seoul, Korea- Republic Of;
P0245: Analysis of quality measurements of colonoscopy at different levels of care in IBDECCO'25Year: 2025
Authors: Bacsur , P.(1);Farkas , B.(1);Ivány , E.(1);Fábián , A.(1);Bor , R.(1);Szepes , Z.(1);Farkas , K.(1,2);Molnár , T.(1)*;
(1)Albert Szent-Györgyi Medical School- University of Szeged, Department of Medicine, Szeged, Hungary;(2)HCEMM-USZ, Translational Colorectal Research Group, Szeged, Hungary;
P0246: Predicting Operative Recurrence in Crohn's Disease Using a Nomogram Incorporating Histopathological FactorsECCO'25Year: 2025
Authors: Zhang, C.(1)*;Zhang, Y.(1);Xiong, S.(1);Zhang, P.(1);Cao, Q.(2);Ye, Z.(2);Qiu, Y.(1);
(1)The First Affiliated Hospital of Sun Yat-sen University, Department of Gastroenterology, Guangzhou, China;(2)The First Affiliated Hospital of Sun Yat-sen University, Department of Pathology, Guangzhou, China;
P0247: Clinical and Colonoscopic Features of Colitis in HIV-Positive Patients Mimicking Inflammatory Bowel Disease Over the Past 12 YearsECCO'25Year: 2025
Authors: KimProf. Dr., W.J.(1)*;Choi, Y.S.(1);Kim, J.K.(1);Paik, N.(1);
(1)DaeHang Hospital, Department of Gastroenterology, Seoul, Korea- Republic Of;
References
P0248: Insomnia as a determinant of poor IBD disease courseECCO'25Year: 2025
Authors: Weintraub, Y.(1)*;Tauman, R.(2);Shouval , D.S.(1);Shamir, R.(1);Kwapisz, L.(3);Rosenberg, S.(4);Dunietz, G.L.(5);
(1)Schneider Children's Medical Center, Institute of Gastroenterology- Nutrition and Liver Diseases, Petach Tikva, Israel;(2)Tel-Aviv Sourasky Medical Center, Sleep Disorders Center, Tel Aviv, Israel;(3)Gastro Health, Gastro Health, Miami, United States;(4)Lynx.MD, Data Analytics, Ramat Gan, Israel;(5)University of Michigan, Division of Sleep Medicine- Department of Neurology, Michigan, United States;
P0249: The Impact of Obesity on the Persistence of Advanced Therapies in Inflammatory Bowel DiseaseECCO'25Year: 2025
Authors: Hsu, W.C.(1)*;Lin, S.H.(1,2);Chiu, H.Y.(3);Kuo, C.J.(1,4,5,6,7);Chen, C.M.(4,8);Su, M.Y.(1,2,4,5,6);Wu, R.C.(1,4,9);Chiu, C.T.(1,4,5,6,7);Chang, C.W.(5,10,11,12);Huang, T.Y.(5,13);Pan, Y.B.(14);Le, P.H.(1,4,5,6,7);
(1)Chang Gung University, School of Medicine, Taoyuan, Taiwan;(2)New Taipei City Municipal Tucheng Hospital, Department of Gastroenterology and Hepatology, New Taipei City, Taiwan;(3)Chang Gung Memorial Hospital- Linkou Branch, Medical Education Committee, Taoyuan, Taiwan;(4)Chang Gung Memorial Hospital- Linkou Branch, Chang Gung Inflammatory Bowel Disease Center, Taoyuan, Taiwan;(5)Taiwan Association for the Study of Small Intestinal Diseases, Taiwan Association for the Study of Small Intestinal Diseases, Taoyuan, Taiwan;(6)Chang Gung Memorial Hospital- Linkou Branch, Chang Gung Microbiota Therapy Center, Taoyuan, Taiwan;(7)Chang Gung Memorial Hospital- Linkou Branch, Department of Gastroenterology and Hepatology, Taoyuan, Taiwan;(8)Chang Gung Memorial Hospital- Linkou Branch, Department of Medical Imaging and Interventions, Taoyuan, Taiwan;(9)Chang Gung Memorial Hospital- Linkou Branch, Department of Anatomic Pathology, Taoyuan, Taiwan;(10)MacKay Memorial Hospital, Division of Gastroenterology- Department of Internal Medicine, Taipei, Taiwan;(11)MacKay Medical College, MacKay Medical College, Taipei, Taiwan;(12)MacKay Junior College of Medicine, Nursing and Management, Taipei, Taiwan;(13)Tri-Service General Hospital, Division of Gastroenterology, Taipei, Taiwan;(14)Chang Gung Memorial Hospital- Linkou Branch, Biostatistical Section- Clinical Trial Center, Taoyuan, Taiwan;
P0250: Circulating blood matrix metalloproteinase (MMP)-10 and 12 can accurately predict mucosal healing in Inflammatory Bowel Disease (IBD) in a multi-centred prospective longitudinal cohort study (2020-2024).ECCO'25Year: 2025
Authors: Cartlidge, P.(1)*;Whelan, R.(1);Siu-Ying Lau, P.(1);Hall, R.(2);Chuah, C.S.(3);Shafi, L.(4);Hodge, M.(1);Ong, S.(1);Le Saint-Grant, A.(1);Brownson, E.(5);Campbell, I.(5);Oddy, A.(6);Poulose, B.(6);Mowat, C.(2);MacDonald, J.(7);Seenan, J.P.(5);Ho, G.T.(1);Kalla, R.(1);
(1)University of Edinburgh, Institute for Regeneration and Repair, Edinburgh, United Kingdom;(2)Ninewells Hospital, Gastroenterology, Dundee, United Kingdom;(3)University of Glasgow, School of Infection and Immunity, Glasgow, United Kingdom;(4)University of Leeds, Leeds Immunogenomics Facility, Leeds, United Kingdom;(5)Queen Elizabeth University Hospital, Gastroenterology, Glasgow, United Kingdom;(6)Western General Hospital, Gastroenterology, Edinburgh, United Kingdom;(7)Glasgow Royal Infirmary, Gastroenterology, Glasgow, United Kingdom;
*PEA-Olink: Proximity Extension Assay